Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. Επικοινωνία Submitted by Στέργιος Πολύζος on Δευ, 11/18/2019 - 11:00
